| Entry |
|
|---|
| Name |
Pralidoxime iodide (JAN/USAN);
Pam (TN) |
|---|
| Formula |
C7H9N2O. I
|
|---|
| Exact mass |
263.9760
|
|---|
| Mol weight |
264.06
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Therapeutic category: | 3929 |
| Product (DG01153): | D00469<US> D01572<JP> |
|
|---|
| Efficacy |
Antidote (organicphosphorus compound), Acetylcholinesterase (AChE) reactivator |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AB Antidotes
V03AB04 Pralidoxime
D01572 Pralidoxime iodide (JAN/USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
392 Antidotes
3929 Others
D01572 Pralidoxime iodide (JAN/USAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
ACHE
D01572 Pralidoxime iodide (JAN/USAN) <JP>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 11
1 C8y C 22.4722 -18.2513
2 N5y N 21.2626 -17.5442 #+
3 C8x C 22.4722 -19.6478
4 C2b C 23.6875 -17.5442
5 C8x C 20.0473 -18.2513
6 C1a C 21.2626 -16.1594
7 C8x C 21.2626 -20.3547
8 N2b N 24.8853 -18.2513
9 C8x C 20.0473 -19.6478
10 O1b O 26.1066 -17.5442
11 X I 19.0124 -17.3806 #-
BOND 10
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 2
7 4 8 2
8 5 9 2
9 8 10 1
10 7 9 1
|
|---|
